Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$245K Buy
27,275
+2,402
+10% +$22K ﹤0.01% 1700
2026
Q1
$231K Buy
24,873
+1,083
+5% +$10.7K ﹤0.01% 1620
2025
Q4
$166K Sell
23,790
-9,277
-28% -$58.3K ﹤0.01% 1573
2025
Q3
$189K Sell
33,067
-6,737
-17% -$36K ﹤0.01% 1566
2025
Q2
$190K Buy
+39,804
New +$228K ﹤0.01% 1515

Other funds holding NEOG

Vident Advisory's NEOG Position: Q2 2026 in Review

Vident Advisory increased its Neogen (NEOG) stake by 9.7% in Q2 2026, buying an estimated $22K and bringing the position to 27,275 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #1700.

Vident Advisory first reported a position in NEOG in Q2 2025 and has held it in 5 quarters since. 316 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

  • Vident Advisory held 27,275 shares of Neogen worth $245K as of Q2 2026.
  • Vident Advisory bought 2,402 Neogen shares in Q2 2026, an estimated $22K.
  • Neogen made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1700 holding.
  • Vident Advisory first reported a position in Neogen in Q2 2025 and has held it in 5 quarters since.
  • 316 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.